Synthetic Mammalian Prions
University of California, San Francisco · Institute for Neurodegenerative Disorders
Abstract
Recombinant mouse prion protein (recMoPrP) produced in Escherichia coli was polymerized into amyloid fibrils that represent a subset of beta sheet-rich structures. Fibrils consisting of recMoPrP(89-230) were inoculated intracerebrally into transgenic (Tg) mice expressing MoPrP(89-231). The mice developed neurologic dysfunction between 380 and 660 days after inoculation. Brain extracts showed protease-resistant PrP by Western blotting; these extracts transmitted disease to wild-type FVB mice and Tg mice overexpressing PrP, with incubation times of 150 and 90 days, respectively. Neuropathological findings suggest that a novel prion strain was created. Our results provide compelling evidence that prions are…
Citation impact
- FWCI
- 39.41
- Percentile
- 100%
- References
- 74
Authors
7- GLGiuseppe LegnameCorresponding
University of California, San Francisco, Institute for Neurodegenerative Disorders
- IVIlia V. BaskakovCorresponding
University of California, San Francisco, Institute for Neurodegenerative Disorders
- HBHoang-Oanh B. Nguyen
University of California, San Francisco, Institute for Neurodegenerative Disorders
- DRDetlev Riesner
University of California, San Francisco, Institute for Neurodegenerative Disorders
- FEFred E. Cohen
University of California, San Francisco, Institute for Neurodegenerative Disorders
Topics & keywords
- Recombinant DNA
- Genetically modified mouse
- Escherichia coli
- Blot
- Fibril
- Prion protein
- Inoculation
- Incubation